BLSH received antitrust clearance in the U.S., UK and Germany for its $4.2 billion acquisition of Equiniti. The deal is still subject to rem

BLSH received antitrust clearance in the U.S., UK and Germany for its $4.2 billion acquisition of Equiniti. The deal is still subject to remaining approvals and customary closing conditions, with completion targeted for January 2027. Equiniti supports nearly 3,000 public companies and processes about $500 billion in annual payments.